MedtechLedger currently links 21 FDA records to the applicant name Inspire Medical Systems. It includes 1 original PMA approval. 7 entries are PMA supplements. 13 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Apr 30, 2014 to Nov 5, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Changes described in PMA records
The FDA recorded decision OK30 on 2026-11-05 for PMA supplement P130008/S148, submitted by Inspire Medical Systems as a 30-Day Notice under the process change category covering manufacturer, sterilizer, packager or supplier. The supplement concerns the Model 4063 Dedicated Tray Sealer and associated outer tray sealing nest equipment used to manufacture the Model 4063 Stimulation Lead. The device category is an implanted hypoglossal nerve stimulator for apnea, listed under the anesthesiology specialty with product code MNQ.
The recorded scope is installation of that sealing equipment for lead manufacture, not a new approval of the underlying system. The source lists no supporting documents, so the review basis and any conditions of the decision remain unknown. Whether the change affects sterility assurance, lead performance or labeling is not stated in the available record, and no clinical or legal conclusion follows from the decision code alone.
FDA approval-order wording
approval for the installation of a new Tray Sealer and associated outer tray sealing nest equipment used for the manufacture of the Model 4063 Stimulation Lead
Nov 5, 2026 · 30-Day NoticeFDA supplement P130008/S144, dated 2026-10-26, records an approval for a minor software update to the Model 2740S SleepSync Programmer Application. The stated purpose is to address known software bugs, improve user experience, and perform code maintenance, including updates to software of unknown provenance (SOUP). The supplement type is Real-Time Process, and the reason is Change Design/Components/Specifications/Material.
This supplement does not represent a new approval of the INSPIRE II Upper Airway Stimulator system. The record identifies the device as a Stimulator, hypoglossal nerve, implanted, apnea under product code MNQ, with the applicant Inspire Medical Systems. The source statement reports the intended scope of the software change but does not provide independent proof of safety or clinical effectiveness for the updated programmer application.
FDA approval-order wording
approval for a minor software update to the Model 2740S SleepSync Programmer Application to address known software bugs, improve user experience, and perform code maintenance which includes updates to software of unknown provenance (SOUP).
Oct 26, 2026 · Real-Time ProcessThe FDA recorded decision OK30 on 2026-10-22 for PMA supplement P130008/S147, submitted by Inspire Medical Systems as a 30-Day Notice under the process change category covering manufacturer, sterilizer, packager or supplier. The supplement concerns the Model 3150 Implantable Pulse Generator, a hypoglossal nerve stimulator for implanted apnea therapy (product code MNQ, listed under anesthesiology).
The recorded scope is expansion of the existing Model 3028 IPG final device manufacturer's site so that it can also produce the Model 3150 IPG. This is a manufacturing-site change within the existing approval, not a new approval of the device or its labeling. The source record includes no documents, so the site identity, inspection status and any conditions attached to OK30 remain unknown, as does whether the Model 3150 differs from the Model 3028 beyond production location.
FDA approval-order wording
approval for the expansion of Inspire Medical's existing Model 3028 Implantable Pulse Generator (IPG) final device manufacturer's site to produce the Model 3150 IPG
Oct 22, 2026 · 30-Day NoticeThe FDA record for P130008/S146, a 30-Day Notice dated 2026-10-13 with decision OK30, describes dimensional changes to the transport fixture used for the Model 3150 Implantable Pulse Generator PCBA. It also covers an added visual inspection of the microcontroller unit before final device assembly. The listed supplement reason is a process change involving manufacturer, sterilizer, packager or supplier; the specialty field is anesthesiology and the product code is MNQ.
The S146 identifier ties this notice to the original P130008 approval for Inspire Medical Systems, but a supplement is not a new approval of the whole system and this is a manufacturing notice, not an original PMA. The statement gives the reported purpose of the changes, not independent proof of safety or clinical effectiveness; it does not describe fixture dimensions, inspection criteria or acceptance limits.
FDA approval-order wording
approval for dimensional modifications to the Model 3150 Implantable Pulse Generator (IPG) PCBA transport fixture and the implementation of an additional visual inspection step of the microcontroller unit (MCU) prior to final device assembly
Oct 13, 2026 · 30-Day NoticeFDA’s recorded scope: Approval for updates to the production endotoxin sampling plan for the Model 3150 Implanted Pulse Generator (IPG).
Aug 28, 2026 · 135 Review Track For 30-Day NoticeSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.